Mammoth Scientific, an Atlanta, GA-based health science and technology venture capital firm, launched a $100m venture capital fund.
Co-founded by Dr. Jay Yadav, Tommy Martin, Kim Mackrill, Dr. Matthew McGirt and Jud Mackrill, Mammoth provides venture capital for health science and technology companies who are maturing beyond seed rounds. The team includes seasoned physician entrepreneurs and operational managers, representing a twenty-year track record of creating and investing in multiple startups with large exits to major global companies (e.g., Abbott Laboratories, Boston Scientific, Johnson & Johnson) or to the public markets.
Mammoth creates venture capital investment pathways for the highly underserved RIA advisory market. Through proprietary fintech, the firm has integrated 2021 SEC and healthcare investment rules. The U.S. RIA market manages more than $5.7 trillion but has historically been hindered from providing venture capital investments to clients due to regulatory challenges, uncertainty around risk and how to best engage clients. Mammoth says it has created a pathway for compliant marketing, sales and management designed to keep wealth managers at the center of their client relationships.
FinSMEs
19/07/2021